Business Description
Anhui Huaren Health Pharmaceutical Co Ltd
ISIN : CNE100005YT4
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.05 | |||||
Equity-to-Asset | 0.4 | |||||
Debt-to-Equity | 0.61 | |||||
Debt-to-EBITDA | 6.2 | |||||
Interest Coverage | 15.33 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 2.15 | |||||
Beneish M-Score | -1.59 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 19.4 | |||||
3-Year EBITDA Growth Rate | 34.3 | |||||
3-Year EPS without NRI Growth Rate | 1 | |||||
3-Year FCF Growth Rate | -41.4 | |||||
3-Year Book Growth Rate | 32.2 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 57.48 | |||||
9-Day RSI | 44.77 | |||||
14-Day RSI | 41.16 | |||||
6-1 Month Momentum % | -22.35 | |||||
12-1 Month Momentum % | -28.57 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.38 | |||||
Quick Ratio | 0.96 | |||||
Cash Ratio | 0.59 | |||||
Days Inventory | 100.99 | |||||
Days Sales Outstanding | 43.93 | |||||
Days Payable | 142.65 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.96 | |||||
Forward Dividend Yield % | 0.96 | |||||
5-Year Yield-on-Cost % | 0.96 | |||||
3-Year Average Share Buyback Ratio | -5.6 | |||||
Shareholder Yield % | -8.39 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 30.85 | |||||
Operating Margin % | 5.33 | |||||
Net Margin % | 3.28 | |||||
FCF Margin % | -3.39 | |||||
ROE % | 6.93 | |||||
ROA % | 3.1 | |||||
ROIC % | 8 | |||||
ROC (Joel Greenblatt) % | 21.98 | |||||
ROCE % | 7.85 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 32.48 | |||||
PE Ratio without NRI | 30 | |||||
PEG Ratio | 0.67 | |||||
PS Ratio | 1.07 | |||||
PB Ratio | 2.13 | |||||
Price-to-Tangible-Book | 3.66 | |||||
Price-to-Operating-Cash-Flow | 45.64 | |||||
EV-to-EBIT | 20.83 | |||||
EV-to-EBITDA | 20.83 | |||||
EV-to-Revenue | 1.01 | |||||
EV-to-FCF | -29.32 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.57 | |||||
Price-to-Graham-Number | 2.21 | |||||
Price-to-Net-Current-Asset-Value | 264.75 | |||||
Earnings Yield (Greenblatt) % | 4.8 | |||||
FCF Yield % | -3.25 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Anhui Huaren Health Pharmaceutical Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 4,055.912 | ||
EPS (TTM) (Â¥) | 0.326 | ||
Beta | 0 | ||
Volatility % | 38.99 | ||
14-Day RSI | 41.16 | ||
14-Day ATR (Â¥) | 0.385919 | ||
20-Day SMA (Â¥) | 10.8215 | ||
12-1 Month Momentum % | -28.57 | ||
52-Week Range (Â¥) | 9.62 - 26.65 | ||
Shares Outstanding (Mil) | 400.01 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Anhui Huaren Health Pharmaceutical Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Anhui Huaren Health Pharmaceutical Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Anhui Huaren Health Pharmaceutical Co Ltd Frequently Asked Questions
What is Anhui Huaren Health Pharmaceutical Co Ltd(SZSE:301408)'s stock price today?
When is next earnings date of Anhui Huaren Health Pharmaceutical Co Ltd(SZSE:301408)?
Does Anhui Huaren Health Pharmaceutical Co Ltd(SZSE:301408) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |